L. Mendeleeva

Plasmablastic Lymphoma with Primary Impairment of Bone Marrow in a HIV-Negative Patient: A Literature Review and a Case Report

A. Kovrigina, Maiya Valerevna Firsova, M.V. Solov’ev, 2022, Clinical oncohematology.

Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation

M. Kattan, N. Kröger, A. Nagler, 2014, Bone Marrow Transplantation.

Infectious Complications in Multiple Myeloma Patients Receiving Various Antitumor Regimens

L. Mendeleeva, G. Klyasova, V. Savchenko, 2019, Clinical oncohematology.

Multiple myeloma with extramedullary plasmacytoma: pathogenesis and clinical case

A. Sudarikov, I. Yakutik, T. Obukhova, 2022, Oncohematology.

Prognostic Value of Bone Marrow Angiogenesis in Patients with Multiple Myeloma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation.

E. Parovichnikova, V. Savchenko, S. Kulikov, 2008 .

Influence of Different Conditioning Regimens on Stroma Precursors

V. Savchenko, L. Gerasimova, S. Kulikov, 1996 .

Magnetic Resonance Imaging of Bone Marrow and its Results as a Criterion for Administration of Maintenance Therapy After Auto-HSCT in Multiple Myeloma Patients

V. Savchenko, G. Yatsyk, M. Solovev, 2018, Clinical Oncohematology.

PS1425 RESULTS OF THE DARATUMUMAB MONOTHERAPY EARLY ACCESS TREATMENT PROTOCOL (EAP) IN PATIENTS FROM EUROPE AND RUSSIA WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

G. Cook, M. Gaudig, C. Couturier, 2019, HemaSphere.

Clinical features of multiple myeloma with bone plasmacytomas

A. Kovrigina, M. Solovev, L. Mendeleeva, 2023, Oncohematology.

Results of Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma(MM) and Renal Impairment: A Retrospective Single-Center Study

M. Solovev, L. Mendeleeva, M. Soloveva, 2024, International journal of hematology-oncology and stem cell research.